Related Experiment Video
Updated: Aug 31, 2025

Visualization of Candida albicans in the Murine Gastrointestinal Tract Using Fluorescent In Situ Hybridization
Published on: November 5, 2019
Et tu Mucor?
Anadi Khatri1, Gunjan Prasai, Mukesh Pandey
1Birat Eye Hospital, Biratnagar, Nepal.
Introduction:
Recently, the Indian subcontinent has been hard hit by the second wave of COVID-19. Along with it, the region has become a hot spot for mucormycosis infection in patients with COVID-19. The aim of this paper is to provide a scientific overview on the status of mucormycosis in pre-COVID-19 era and on how COVID-19 could have directly or indirectly expose the hidden burden of mucormycosis globally.
Materials And Methods:
This paper is structured as a narrative review and is based on relevant published literature on both COVID-19 and mucormycosis.
Conclusion:
Mucormycosis in the pre-COVID-19 era was almost a neglected entity. It was because the risk factors for both - More severe COVID-19 infections and Mucormycosis are almost similar - COVID-19 might have helped to expose the true magnitude of the mucormycosis and flagging it as a major public health concern requiring a revisit by medical science.
Related Concept Videos
Fungal Group Zygomycota
Mucosal Barrier of the Stomach
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Fungal Phylum Ascomycota
Overview of Fungi
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Fungal Phylum Basidiomycota

